AMRX Archives - Market Exclusive

Home Tags AMRX

Amneal Pharmaceuticals Inc (NYSE:AMRX) gets downgraded to Market Perform by Svb...

ME Staff - March 8, 2019

Amneal Pharmaceuticals Inc (NYSE:AMRX) gets downgraded to Equal Weight by Morgan...

ME Staff - December 14, 2018

Amneal Pharmaceuticals Inc (NYSE:AMRX) gets downgraded to Hold by SunTrust Banks...

ME Staff - October 16, 2018

Amneal Pharmaceuticals Inc (NYSE:AMRX) gets downgraded to Hold by SunTrust Banks

ME Staff - October 16, 2018

Amneal Pharmaceuticals Inc (NYSE:AMRX) price target lowered to $24.00 by Morgan...

ME Staff - October 3, 2018

Amneal Pharmaceuticals Inc (NYSE:AMRX) had its Buy rating reiterated by Morgan...

ME Staff - October 3, 2018

Amneal Pharmaceuticals Inc (NYSE:AMRX) price target raised to $28.00 by B....

ME Staff - August 22, 2018

Amneal Pharmaceuticals Inc (NYSE:AMRX) price target raised to $21.00 by Canaccord...

ME Staff - August 14, 2018

Amneal Pharmaceuticals Inc (NYSE:AMRX) price target raised to $20.00 by BMO...

ME Staff - August 10, 2018

Analyst Activity – JPMorgan Chase Initiates Coverage On NYSE:AMRX – Amneal...

ME Staff - May 18, 2018

/* */

EDITOR PICKS

Market Morning: JD CEO Sued, Qualcomm Wins While Intel Exits, Fink...

April 17, 2019

Cannabis Stock News Daily Roundup April 17

April 17, 2019

Cannabis Stock News Daily Roundup April 15

April 15, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: AMRX